175 related articles for article (PubMed ID: 11493445)
1. Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase.
Hadjur S; Ung K; Wadsworth L; Dimmick J; Rajcan-Separovic E; Scott RW; Buchwald M; Jirik FR
Blood; 2001 Aug; 98(4):1003-11. PubMed ID: 11493445
[TBL] [Abstract][Full Text] [Related]
2. Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution.
Haneline LS; Li X; Ciccone SL; Hong P; Yang Y; Broxmeyer HE; Lee SH; Orazi A; Srour EF; Clapp DW
Blood; 2003 Feb; 101(4):1299-307. PubMed ID: 12393504
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic correction of Fanconi anemia group C knockout mice.
Gush KA; Fu KL; Grompe M; Walsh CE
Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
[TBL] [Abstract][Full Text] [Related]
4. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
[TBL] [Abstract][Full Text] [Related]
5. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability.
Haneline LS; Gobbett TA; Ramani R; Carreau M; Buchwald M; Yoder MC; Clapp DW
Blood; 1999 Jul; 94(1):1-8. PubMed ID: 10381491
[TBL] [Abstract][Full Text] [Related]
6. Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc-/- mice.
Li X; Yang Y; Yuan J; Hong P; Freie B; Orazi A; Haneline LS; Clapp DW
Blood; 2004 Aug; 104(4):1204-9. PubMed ID: 15113761
[TBL] [Abstract][Full Text] [Related]
7. In vivo administration of interferon gamma does not cause marrow aplasia in mice with a targeted disruption of FANCC.
Kurre P; Anandakumar P; Grompe M; Kiem HP
Exp Hematol; 2002 Nov; 30(11):1257-62. PubMed ID: 12423678
[TBL] [Abstract][Full Text] [Related]
8. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA.
Pang Q; Keeble W; Diaz J; Christianson TA; Fagerlie S; Rathbun K; Faulkner GR; O'Dwyer M; Bagby GC
Blood; 2001 Mar; 97(6):1644-52. PubMed ID: 11238103
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control.
Li X; Plett PA; Yang Y; Hong P; Freie B; Srour EF; Orschell CM; Clapp DW; Haneline LS
Blood; 2003 Sep; 102(6):2081-4. PubMed ID: 12763929
[TBL] [Abstract][Full Text] [Related]
10. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy.
Li X; Le Beau MM; Ciccone S; Yang FC; Freie B; Chen S; Yuan J; Hong P; Orazi A; Haneline LS; Clapp DW
Blood; 2005 May; 105(9):3465-71. PubMed ID: 15644418
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines.
Hadjur S; Jirik FR
Blood; 2003 May; 101(10):3877-84. PubMed ID: 12521994
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.
Aubé M; Lafrance M; Charbonneau C; Goulet I; Carreau M
Stem Cells; 2002; 20(5):438-47. PubMed ID: 12351814
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.
Freie B; Li X; Ciccone SL; Nawa K; Cooper S; Vogelweid C; Schantz L; Haneline LS; Orazi A; Broxmeyer HE; Lee SH; Clapp DW
Blood; 2003 Dec; 102(12):4146-52. PubMed ID: 12855557
[TBL] [Abstract][Full Text] [Related]
15. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
16. Ruxolitinib ameliorates progressive anemia and improves survival during episodes of emergency granulopoiesis in Fanconi C
Hasan S; Hu L; Williams O; Eklund EA
Exp Hematol; 2022 May; 109():55-67.e2. PubMed ID: 35278531
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
18. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
[TBL] [Abstract][Full Text] [Related]
19. Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions.
Broxmeyer HE; Capitano ML; Cooper S; Potchanant ES; Clapp DW
Blood Cells Mol Dis; 2021 Feb; 86():102492. PubMed ID: 32896825
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles of stress-activated protein kinases in Fanconi anemia-type C-deficient hematopoiesis.
Saadatzadeh MR; Bijangi-Vishehsaraei K; Kapur R; Haneline LS
Blood; 2009 Mar; 113(12):2655-60. PubMed ID: 19168785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
